AIRWA INC. (YYAI): Nasdaq/NYSE listing notice — Connexa receives Nasdaq delisting notice for non-compliance with independent director and audit committee requirements

AIRWA INC.

Board currently has only 2 independent directors out of 4; audit committee has only 2 independent directors, violating Rule 5605.
Cure period until the earlier of next annual meeting or June 12, 2026; if annual meeting before Dec 9, 2025, compliance due Dec 9, 2025.
Company intends to appoint an additional independent director to serve on Board and Audit Committee before cure period ends.
Notice has no immediate effect on listing or trading of common stock (ticker YYAI).

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

AIRWA INC. received a nasdaq deficiency notice notice regarding board independence (rules 5605, 5605(b)(1)(A), 5605(c)(4)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: board independence
Rules: 5605, 5605(b)(1)(A), 5605(c)(4)

Exact text from the filing

July 9, 2025, Connexa Sports Technologies Inc. (the “ Company ”) received a letter (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that, as a result of Warren Andrew Thomson’s resignation from the Board of Directors of the Company (the “ Board ”) and the audit committee of the Board (the “ Audit Committee ”), effective June 12, 2025, the Company is not currently in compliance with Nasdaq Listing Rule 5605. The Notice has no immediate effect on the listing or trading of the Company’s common stock. Nasdaq Listing Rule 5605 requir

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

AIRWA INC. filing history →

Source: SEC EDGAR

accession 0001641172-25-019713

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.